Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study compares radioembolization ((90)Y) versus doxorubicin drug eluting beads (DEBDOX) in the treatment of unresectable hepatocellular carcinoma with portal vein thrombosis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Surg Oncol

Title: Surgical oncology

Publisher: Elsevier BV

ISSN (Electronic): 1879-3320

ISSN (Print): 0960-7404

Publication date (Electronic): Sep 2015

Volume: 24

Issue: 3

Affiliations

[1 ] Department of Radiology, University of Louisville, United States. Electronic address: okakin01@louisville.edu.

[2 ] University of Louisville Medical School, United States. Electronic address: d0kim016@louisville.edu.

[3 ] University of Louisville Medical School, United States. Electronic address: jacob.edwards@louisville.edu.

[4 ] Department of Surgical Oncology, University of Louisville, United States. Electronic address: Russell.brown@infirmaryhealth.org.

[5 ] Department of Surgical Oncology, University of Louisville, United States. Electronic address: prejesh.philips@louisville.edu.

[6 ] Department of Surgical Oncology, University of Louisville, United States. Electronic address: charles.scoggins@louisville.edu.

[7 ] Department of Surgical Oncology, University of Louisville, United States. Electronic address: Robert.Martin@louisville.edu.

Article

Publisher Item ID: S0960-7404(15)30008-6

DOI: 10.1016/j.suronc.2015.06.008

PubMed ID: 26133576

SO-VID: c452549a-7b96-4735-8bb5-3cf677b81907

History

Keywords: Comparative,DEBTACE,Efficacy,RECIST,Toxicity

Data availability:

Keywords: Comparative, DEBTACE, Efficacy, RECIST, Toxicity

Comments

Comment on this article

scite_

Cited by 8

See all cited by